Early Anti-CD20 and CNS Penetrant BTK Inhibition to Enhance OPC-Driven Remyelination in Multiple Sclerosis. Vivekanandan N, Kumudhavalli MV, Kumar M CNS Neurol Disord Drug Targets. 2026 Apr 09. PMID: 42299013. Abstract CommentRecommendBookmarkWatch
